Centralized laboratory for studying cancer in people living with HIV
Official title: Central Laboratory Core
Funded at H. Lee Moffitt Cancer Ctr & Res Inst · NIH-10898569 · Data updated 2026-11-12
This study is looking to gather and study samples from people living with HIV to learn more about how HIV might be linked to cancer, with the goal of finding better ways to prevent and treat cancer for those in low- and middle-income countries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project start | August 3, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $242,812 |
| NIH project number | 5U54CA277834-02 |
| Project ID | NIH-10898569 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV, particularly those in low- and middle-income countries.
✕Less likely to help
Patients who do not have HIV or are not affected by cancer may not receive any benefit from this research.
What this research studies
This research focuses on creating a centralized laboratory that will collect and analyze biological samples from individuals living with HIV to better understand the relationship between viral infections and cancer. The laboratory will utilize advanced virologic and immunologic assessment techniques to evaluate well-annotated biospecimens. By collaborating with international partners, the project aims to develop effective cancer prevention and treatment strategies specifically tailored for populations in low- and middle-income countries affected by HIV.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer prevention and treatment options for people living with HIV.
How similar studies have gone: Previous research has shown success in using centralized biobanking and collaborative international studies to improve health outcomes for populations affected by HIV and cancer.
Where this research is happening
-
H. Lee Moffitt Cancer Ctr & Res Inst
Tampa, United States Active
Researchers
- Principal investigator: Schneider, Johann Wilhelm — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Schneider, Johann Wilhelm
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.